S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
NASDAQ:TMCI

Treace Medical Concepts News Headlines

$29.35
+0.22 (+0.76 %)
(As of 09/24/2021 12:00 AM ET)
Add
Compare
Today's Range
$28.38
$29.61
50-Day Range
$24.15
$30.26
52-Week Range
$22.46
$37.17
Volume96,800 shs
Average Volume235,236 shs
Market Capitalization$1.55 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Media Mentions By Week

Treace Medical Concepts Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

TMCI
News Sentiment

0.00

0.35

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

TMCI Articles
This Week

1

1

TMCI Articles
Average Week

Get Treace Medical Concepts News Delivered to You Automatically

Sign up to receive the latest news and ratings for TMCI and its competitors with MarketBeat's FREE daily newsletter.

Treace Medical Concepts (NASDAQ TMCI) News Headlines Today

SourceHeadline
Treace Announces New ALIGN3D™ Data at the 2021 AOFAS Annual MeetingTreace Announces New ALIGN3D™ Data at the 2021 AOFAS Annual Meeting
finance.yahoo.com - September 23 at 6:17 PM
Treace Medical Concepts (NASDAQ:TMCI)  Shares Down 4.8% Treace Medical Concepts (NASDAQ:TMCI) Shares Down 4.8%
americanbankingnews.com - September 15 at 11:54 AM
Treace Medical Concepts (NASDAQ:TMCI) Shares Gap Down to $27.70Treace Medical Concepts (NASDAQ:TMCI) Shares Gap Down to $27.70
americanbankingnews.com - September 14 at 11:34 AM
Treace Announces Launch of Adductoplasty™ Instrumented Midfoot Correction SystemTreace Announces Launch of Adductoplasty™ Instrumented Midfoot Correction System
finance.yahoo.com - September 13 at 8:23 PM
Reviewing ShockWave Medical (NASDAQ:SWAV) and Treace Medical Concepts (NASDAQ:TMCI)Reviewing ShockWave Medical (NASDAQ:SWAV) and Treace Medical Concepts (NASDAQ:TMCI)
americanbankingnews.com - September 8 at 3:18 PM
Treace Medical Concepts (NASDAQ:TMCI) Trading Up 7.3%Treace Medical Concepts (NASDAQ:TMCI) Trading Up 7.3%
americanbankingnews.com - September 7 at 1:19 PM
Treace Announces Participation in the Morgan Stanley 19th Annual Global Healthcare ConferenceTreace Announces Participation in the Morgan Stanley 19th Annual Global Healthcare Conference
finance.yahoo.com - September 2 at 4:21 PM
Treace Announces New Supportive ALIGN3D™ Data to be Presented at the 2021 AOFAS Annual MeetingTreace Announces New Supportive ALIGN3D™ Data to be Presented at the 2021 AOFAS Annual Meeting
finance.yahoo.com - September 1 at 6:08 PM
Treace Medical Concepts Inc Shares Approach 52-Week Low - Market MoverTreace Medical Concepts Inc Shares Approach 52-Week Low - Market Mover
nasdaq.com - August 17 at 5:46 AM
Treace Medical Concepts, Inc. (TMCI) Q2 2021 Earnings Call TranscriptTreace Medical Concepts, Inc. (TMCI) Q2 2021 Earnings Call Transcript
fool.com - August 8 at 3:21 AM
Treace Medical Concepts Reports Second Quarter 2021 Financial ResultsTreace Medical Concepts Reports Second Quarter 2021 Financial Results
finance.yahoo.com - August 5 at 7:21 PM
Treace to Report Second Quarter 2021 Financial Results on August 5, 2021Treace to Report Second Quarter 2021 Financial Results on August 5, 2021
finance.yahoo.com - July 27 at 7:19 PM
Treace Medical Concepts Enters Oversold Territory (TMCI)Treace Medical Concepts Enters Oversold Territory (TMCI)
nasdaq.com - July 23 at 6:19 PM
How Much Of Treace Medical Concepts, Inc. (NASDAQ:TMCI) Do Insiders Own?How Much Of Treace Medical Concepts, Inc. (NASDAQ:TMCI) Do Insiders Own?
finance.yahoo.com - July 23 at 1:14 PM
Treace Medical Concepts, Inc.Treace Medical Concepts, Inc.
realmoney.thestreet.com - June 5 at 7:14 PM
Treace Medical Concepts Inc to Host Earnings CallTreace Medical Concepts Inc to Host Earnings Call
finance.yahoo.com - May 25 at 6:20 PM
Treace Medical Concepts Reports First Quarter 2021 Financial ResultsTreace Medical Concepts Reports First Quarter 2021 Financial Results
finance.yahoo.com - May 25 at 6:20 PM
Treace Medicals Lapiplasty 3D Associated With Early Weightbearing After Foot Surgery, Interim Data ShowsTreace Medical's Lapiplasty 3D Associated With Early Weightbearing After Foot Surgery, Interim Data Shows
msn.com - May 19 at 5:31 PM
Treace Announces Interim Results from ALIGN3D™ Clinical Study at ACFAS 2021Treace Announces Interim Results from ALIGN3D™ Clinical Study at ACFAS 2021
finance.yahoo.com - May 19 at 5:31 PM
Treace to Report First Quarter 2021 Financial Results on May 25, 2021Treace to Report First Quarter 2021 Financial Results on May 25, 2021
benzinga.com - May 18 at 8:09 AM
Treace to Announce Interim Results from ALIGN3D™ at ACFAS 2021Treace to Announce Interim Results from ALIGN3D™ at ACFAS 2021
finance.yahoo.com - May 12 at 10:37 AM
Treace Medical Concepts, Inc. Rings the Nasdaq Stock Market Opening Bell in Celebration of its IPOTreace Medical Concepts, Inc. Rings the Nasdaq Stock Market Opening Bell in Celebration of its IPO
nasdaq.com - May 7 at 3:23 PM
Treace Medical Concepts Inc (TMCI) CEO John T. Treace Sold $89.3 million of SharesTreace Medical Concepts Inc (TMCI) CEO John T. Treace Sold $89.3 million of Shares
ca.finance.yahoo.com - May 1 at 11:53 PM
Treace Medical Concepts IncTreace Medical Concepts Inc
reuters.com - April 27 at 9:54 AM
UPDATE - Treace Medical Concepts Announces Pricing of Upsized Initial Public OfferingUPDATE - Treace Medical Concepts Announces Pricing of Upsized Initial Public Offering
finance.yahoo.com - April 26 at 8:33 AM
Five Companies Began Trading on FridayFive Companies Began Trading on Friday
finance.yahoo.com - April 26 at 8:33 AM
Get Treace Medical Concepts News Delivered to You Automatically

Sign up to receive the latest news and ratings for TMCI and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 9/27/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.